New drug SG301 tested in blood cancer patients who have run out of options
NCT ID NCT04684108
First seen Apr 12, 2026 · Last updated May 22, 2026 · Updated 5 times
Summary
This early-stage study tests a new drug called SG301 in 61 people with blood cancers like multiple myeloma that have returned or not responded to standard treatments. The main goal is to check the drug's safety and find the best dose. Researchers will also look at how the drug moves through the body and whether it helps control the cancer.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RELAPSED OR REFRACTORY MULTIPLE MYELOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Affiliated Beijing Chaoyang Hospital of Capital Medical University
Beijing, Beijing Municipality, 100020, China
-
Beijing Jishuitan Hostipal
Beijing, Beijing Municipality, 100032, China
-
Henan Cancer Hospital
Zhengzhou, Henan, 450003, China
-
Qilu Hospital of Shandong University
Jinan, Shandong, 250063, China
-
Shanxi Norman Bethune Hospital
Taiyuan, Shanxi, 030032, China
-
Shengjing Hospital Affiliated to China Medical University
Shenyang, Liaoning, 110136, China
-
Shenzhen Second People's Hospital
Shenzhen, Guangzhou, 518025, China
-
The First Affiliated Hospital of Bengbu Medical College
Bengbu, Anhui, 233099, China
-
The First Affiliated Hospital of China Medical University
Shenyang, Liaoning, 110002, China
-
The Fourth Affiliated Hospital of Hebei Medical University
Shijiazhuang, Hebei, 050011, China
-
The Second Affiliated Hospital of Zhejiang University School of Medicine
Hangzhou, Zhejiang, 310003, China
-
Wuhan University Central South Hospital
Wuhan, Hubei, 430062, China
-
Wuxi Central Hospital
Wuxi, Jiangsu, 214125, China
-
Xiangyang Central Hospital
Xiangyang, Hubei, 441021, China
Conditions
Explore the condition pages connected to this study.